Skip to content
Home/Companies/Healthcare/Kainova Therapeutics
Kainova Therapeutics

Kainova Therapeutics

Healthcare·Canada·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Kainova Therapeutics?

Kainova Therapeutics is currently owned by Seventure Partners through Health for Life Capital (2014 vintage), since 2026.

Hand-verified · updated 2026-04-21

Seventure Partners
Investor
Seventure Partners
Health for Life Capital · 2014 · VC

Key facts

HQCanada
SectorHealthcare
Websitewww.kainovatx.com

More from Health for Life Capital

Other portfolio companies in the same fund.

Clinical Microbiomics
Active
MaaT Pharma
MaaT Pharma
Active
BiotechFrance· 2026
Microbiotica
Microbiotica
Active
BiotechUK· 2026
Standing Ovation
Active
BiotechFrance· 2026
Sunrise
Sunrise
Active
MedTechBelgium· 2024
Cmbio –...
Cmbio –...
Active
BiotechDenmark· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Kainova Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Kainova Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Kainova Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue